SUPN - Supernus Pharmaceuticals, Inc. Qarzning balans kapitallashuviga nisbati
Markaziy nerv tizimi terapiyalariga bo'lgan barqaror talab Supernus Pharmaceuticals (SUPN) kompaniyasini bashorat qilinadigan pul oqimi bilan ta'minlaydi. Biroq, Trokendi XR dori vositasining eksklyuzivlik huquqini yo'qotishi va Parkinson kasalligini davolovchi nasosning tasdiqlanishiga oid qiyinchiliklar moliyaviy bosimni keltirib chiqarmoqda va ushbu ko'rsatkich 0.04 darajasida turibdi. Biznes tadqiqotlar va ishlanmalarga (R&D) e'tibor qaratish uchun dori vositalarini ishlab chiqarishda uchinchi tomonlarga tayanadi. GURU.Markets platformasidagi bozor narxining ushbu grafigi mazkur neyrofarmatsevtika aktivining narx dinamikasini vizuallashtiradi.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_SUPN_-_Supernus-Pharmaceuticals_-_Debt-to-Net-Assets-Ratio "Supernus - SUPN Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Supernus Pharmaceuticals, Inc. (SUPN) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Supernus Pharmaceuticals|SUPN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Supernus Pharma|SUPN - Kompaniyaning jamlangan qarzdorligi|Balans kapitallashuviga qarzlar Supernus Corp|SUPN - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi Supernus
Kompaniyaning fundamental tahlili:Supernus Pharmaceuticals - SUPN
Nevrologiya farmatsevtikasi sektorida qarzdorlikning kapitalga nisbati kritik ahamiyatga ega, chunki u moliyaviy leverajni va sof aktivlarning yo'qolish xavfini baholash imkonini beradi. Umumiy qarzdorlikni bozor kapitalizatsiyasiga nisbatan tahlil qilish orqali investor Supernus Pharmaceuticals (SUPN) kompaniyasining patent risklariga va generik raqobatga bardosh berish qobiliyatini aniqlaydi hamda kompaniya balansining umumiy barqarorlik tuzilmasini baholaydi.
Supernus Pharmaceuticals kimlar bilan raqobatlashadi
Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|XENE (Xenon Corp) - Balans qiymatiga qarzlar|VKTX: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar catalystpharma.com (CPRX)|Qarzning balans qiymatiga nisbati DNLI|Balans kapitallashuviga qarzlar HRMY (Harmony Biosciences Inc)|Biohaven Pharmaceutical (BHVN) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Amylyx Corp AMLX|TRVI (Trevi Therapeutics) - Balans kapitallashuviga qarzlar|PRAX: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Anavex Life Sciences Corp. AVXL|CBLL (CeriBell Inc) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Prothena Corporation (PRTA)|Qarzning balans qiymatiga nisbati Alector Therapeutics (ALEC)|Qarzning balans qiymatiga nisbati ANNX|Balans kapitallashuviga qarzlar OMER (omeros.com)|Qarzning balans kapitallashuviga nisbati NGNE|ACIU - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati Voyager Pharma (VYGR)|NMRA: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Scilex Holding Company (SCLX)|tevogen.com (TVGN) - Qarzlarning balans kapitallashuviga nisbati|ACOG - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Cognition Therapeutics Inc.|Balans kapitallashuviga qarzlar IKT|Balans kapitallashuviga qarzlar SAVA (Cassava Pharma)|Qarzning balans kapitallashuviga nisbati Assertio|Coya Therapeutics Inc - Qarzning sof aktivlarga nisbati|VTGN: Qarzning balans kapitallashuviga nisbati|OVID - Qarzning balans qiymatiga nisbati|ABOS: Balans kapitallashuviga qarzlar|CervoMed Corporation (CRVO) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar ATHE|Qarzning balans qiymatiga nisbati Clene Nanomedicine|PepGen Inc. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Jupiter Neurosciences, Inc. JUNS|Qarzning balans qiymatiga nisbati RLMD (Relmada)|ANVS - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Grace Tx GRCE|AIFF - Qarzning balans kapitaliga nisbati|anewmeds.com - Balans kapitallashuviga qarzlar|NeuroSense Therapeutics Ltd. (NRSN) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar RVPH|Qarzning balans qiymatiga nisbati MetaVia, Inc.|Balans kapitallashuviga qarzlar NRXS|Balans kapitallashuviga qarzlar HSDT (heliusmedical.com)|Qarzning balans kapitallashuviga nisbati Passage Bio PASG|Neuphoria Therapeutics, Inc. - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati NERV (Minerva Neurosciences Corp)|ATHA: Sof aktivlarga qarzlar|Addex Therapeutics - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Alzamend Neuro|CYCN (Cyclerion Therapeutics Inc.) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PTIX|KTTA - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati CRGT (cortigent.com)|ATXI - Qarzning balans kapitallashuviga nisbati|brainstorm-cell.com - Qarzning balans qiymatiga nisbati|Cara Therapeutics (CARA) - Qarzning balans kapitallashuviga nisbati|CHRO - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar ELYM|Balans qiymatiga qarzlar Intra-Cellular Therapies, Inc.|LBPH (Longboard Pharmaceuticals) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar MRNS|NKGen Biotech (NKGN) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati NRBO (NeuroBo Pharmaceuticals Inc)|SAGE: Qarzning balans kapitallashuviga nisbati|Synaptogenix, Inc - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati TRVN (Trevena, Inc.)|Vigil Neuroscience (VIGL) - Sof aktivlarga qarzlar|WENA: Qarzning balans qiymatiga nisbati|CERE (Cerevel Therapeutics Inc) - Balans kapitallashuviga qarzlar